Clinical trial
Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant
NCT03389360 is registered in ClinicalTrials.gov with National Hepatology & Tropical Medicine Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant
- Lead sponsor
- National Hepatology & Tropical Medicine Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 15, 2018
- Completion date
- February 10, 2019
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver transplant infection